Detail of the clinical trial

Title of the trial A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
EudraCT number 2017-003229-14
Protocol number I6T-MC-AMAN
Sponsor Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States of America
Indications Internal medicine
Diagnosis ulcerative colitis
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 16.8.2018
Date of approval by EC 27.6.2018
Date of initiation CT in ČR 22.11.2018
Date of ending CT in ČR
Notice
Sites PreventaMed s.r.o. Vila zdravi,N/A,Domovina 2,Olomouc,779 00
Mediendo s.r.o.,N/A,Thámova 183/11,Praha 8,186 00
Fakultní nemocnice u sv. Anny v Brně,II. Interní klinika,Pekařská 53,Brno,656 91
Gregar s.r.o.,N/A,Čajkovského 67/14,Olomouc,779 00
A-SHINE Plzeň,N/A,Smrkova 23,Plzeň,312 00
Hepato-Gastroenterologie HK, s.r.o.,N/A,třída Edvarda Beneše 1549,Hradec Králové,500 12
Fakultni nemocnice Kralovske Vinohrady,II. Interní klinika,Šrobárova 50,Praha 10,100 34
ISCARE a.s,Českomoravská 2510/19, Praha 9 - Libeň, 190 00
Klinika ResTrial ,Gastroenterologie, ,Sofijské náměstí 3404/3,Praha,143 00
Vojenská nemocnice Brno,Interní oddělení,Zabrdovická 3,Brno ,636 00

‹‹ Back to list